Rajesh Kumar, Senior Director of Structural Biology at Schrodinger, shares with Diana Turner how advanced computational models are supercharging modern drug discovery and the impact they could have in the future.    DT: Can you tell us a bit more about Schrödinger and what you do? RK: Schrödinger’s (SDGR) core objective is to empower science-driven […]